By Brent Balinski You may be familiar with various implants used to heal damaged bones – screws, rods, plates and other metal bits and pieces, ones fashioned from newer varieties of materials engineered to mimic what they replace, grafts from elsewhere on a patient’s body etcetera. Dr Maryam Parviz, a biomedical engineer and co-founder/CEO at…
FDA accepts Mesoblast’s responses Biotech company Mesoblast has announced that the United States Food and Drug Administration (FDA) has accepted Mesoblast’s Biologics License Application (BLA) resubmission for Ryoncil (remestemcel-L) in the treatment of children with steroid-refractory acute graft versus host disease (SR-aGVHD). According to a statement, the FDA considers the resubmission to be a complete…
Brain imaging company EMVision Medical Devices has completed fabrication of the company’s First Responder (Gen 2) Proof of Concept device (pictured). The First Responder device represents an opportunity to fundamentally transform stroke and traumatic brain injury outcomes for patients by delivering neurodiagnostic technology directly to the point of care, including in ambulances, according to the…
Whyalla steel works produces first structural steel The Managing Director of Liberty Steel Group Tony Swiericzuk at Whyalla in South Australia has celebrated the completion of repairs and start up activities at the primary steel producer. Swiericzuk took to social media and said: “After a 48 hour reheat furnace start up programme, the Whyalla Steelworks…
Medical device manufacturer Nova Eye Medical has reported strong sales growth of its glaucoma surgical devices for the year ended 30 June 2024. Revenue for the year ended 30 June 2024, mainly for sales of its ITrack Advance glaucoma surgical device, is expected to be $23.5 million (US$15.3 million), up 37 percent on the previous…
The medtech sector needs further investment in manufacturing to protect against further potential global shocks as medical supply chains in Australia have not recovered fully from the COVID-19 pandemic which caused havoc with patient care. By Dr Jack Richards. In the face of threats like pandemics and shifting economic and geopolitical conditions, it’s imperative that…
Medtech business Headsafe has commercialised Nurochek, a portable headset for concussion screening which it calls its “brain scanner in a briefcase”, and which has been approved for sale in the United States. According to a statement from Headsafe and the Advanced Manufacturing Growth Centre – which supported development of Nurochek through a $447,500 Commercialisation Fund…
The Victorian government has announced a round of 20 grants valued at $50,000 each the companies under the Medtech Market Growth Program. The funding was announced at the office of medtech startup Livac on Monday morning. Livac is developing a medical device (pictured) to help safely retract the liver during surgery. Livac and novel blood pressure…
IDT Australia to raise $7 million for mRNA vaccine production Pharmaceutical manufacturer IDT Australia is to raise $7 million a fully underwritten entitlement offer of fully paid ordinary shares to eligible shareholders. The funds raised will be used to fund capital expenditure relating to current and potential future works in the mRNA therapeutics field including…
Microscopic imaging technology company Optiscan Imaging has revealed an innovative new medical imaging device, InVue, which is designed to enable precision surgery through real-time digital pathology. Manufactured in Melbourne in partnership with industrial design firm Design + Industry, InVue is a significant milestone for the company, traditionally known for its confocal microscope devices. Optiscan CEO…